Geode Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Sell |
|
|||||
|
2025
Q1 | $25.1M | Buy |
|
|||||
|
2024
Q4 | $27.6M | Sell |
|
|||||
|
2024
Q3 | $28.5M | Sell |
|
|||||
|
2024
Q2 | $23.6M | Buy |
|
|||||
|
2024
Q1 | $22.6M | Buy |
|
|||||
|
2023
Q4 | $7.75M | Buy |
|
|||||
|
2023
Q3 | $5.12M | Buy |
|
|||||
|
2023
Q2 | $8.1M | Buy |
|
|||||
|
2023
Q1 | $7.68M | Buy |
|
|||||
|
2022
Q4 | $3.96M | Buy |
|
|||||
|
2022
Q3 | $5.69M | Buy |
|
|||||
|
2022
Q2 | $5.43M | Sell |
|
|||||
|
2022
Q1 | $6.75M | Buy |
|
|||||
|
2021
Q4 | $9.18M | Buy |
|
|||||
|
2021
Q3 | $13.1M | Buy |
|
|||||
|
2021
Q2 | $18.5M | Buy |
|
|||||
|
2021
Q1 | $20.2M | Buy |
|
|||||
|
2020
Q4 | $22.6M | Buy |
|
|||||
|
2020
Q3 | $6.74M | Buy |
|
|||||
|
2020
Q2 | $6.77M | Buy |
|
|||||
|
2020
Q1 | $3.25M | Buy |
|
|||||
|
2019
Q4 | $2.26M | Buy |
|
|||||
|
2019
Q3 | $1.61M | Buy |
|
|||||
|
2019
Q2 | $2M | Buy |
|
|||||
|
2019
Q1 | $1.61M | Buy |
|
|||||
|
2018
Q4 | $1.4M | Buy |
|
|||||
|
2018
Q3 | $2.09M | Buy |
|
|||||
|
2018
Q2 | $1.95M | Buy |
|
|||||
|
2018
Q1 | $1.53M | Buy |
|
|||||
|
2017
Q4 | $783K | Sell |
|
|||||
|
2017
Q3 | $1.16M | Buy |
|
|||||
|
2017
Q2 | $1.69M | Buy |
|
|||||
|
2017
Q1 | $1.63M | Buy |
|
|||||
|
2016
Q4 | $1.16M | Buy |
|
|||||
|
2016
Q3 | $934K | Buy |
|
|||||
|
2016
Q2 | $377K | Buy |
|
|||||
|
2016
Q1 | $680 | Buy |
|
|||||
|
2015
Q4 | $649K | Buy |
|
|||||
|
2015
Q3 | $960K | Buy |
|
|||||
|
2015
Q2 | $1.35M | Buy |
|
|||||
|
2015
Q1 | $1.48M | Buy |
|
|||||
|
2014
Q4 | $669K | Buy |
|
|||||
|
2014
Q3 | $229K | Buy |
|